Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	323.21	452.19	538.5	337.84	598.78	282.65
Short-Term Investments	3,044	25.27	6.16	5.87	14.67	13.85
Cash & Short-Term Investments	3,368	477.46	544.66	343.71	613.45	296.5
Cash Growth	605.33%	-12.34%	58.46%	-43.97%	106.90%	-32.12%
Accounts Receivable	2,992	2,215	1,964	1,933	1,060	702.43
Other Receivables	-	-	-	-	168.99	-
Receivables	2,992	4,947	2,486	2,337	1,229	702.43
Inventory	2,689	1,992	1,972	1,279	1,033	1,004
Other Current Assets	4,385	1,566	1,301	1,016	605.59	623.57
Total Current Assets	13,433	8,982	6,444	5,216	3,786	2,669
Property, Plant & Equipment	6,131	5,659	4,371	3,319	3,391	2,201
Long-Term Investments	-	1.06	1.03	0.87	0.63	1.1
Other Long-Term Assets	-	-	-	0	-	-
Total Assets	19,589	14,642	10,816	8,536	7,177	4,871
Accounts Payable	1,686	176.08	32.51	113.67	-27.09	29.77
Accrued Expenses	-	682.61	448.83	354.26	232.32	145.47
Short-Term Debt	6,309	6,500	3,413	1,884	1,535	1,061
Current Portion of Long-Term Debt	979.3	182.55	216.01	225.9	153.89	139.5
Current Portion of Leases	-	-	-	-	-	9.67
Current Income Taxes Payable	347.86	55.8	258.59	-18.65	-	-139.56
Other Current Liabilities	28.01	216.86	305.13	233.92	159.91	71.15
Total Current Liabilities	9,350	7,814	4,674	2,793	2,054	1,317
Long-Term Debt	2,918	772.48	197.91	387.75	493.02	554.62
Long-Term Leases	-	-	-	-	-	19.8
Long-Term Deferred Tax Liabilities	161.9	113.44	-	-	-	-
Total Liabilities	13,138	8,700	4,872	3,180	2,547	1,892
Common Stock	2,310	2,310	2,310	2,310	2,310	2,310
Retained Earnings	3,297	2,565	2,404	1,639	738.74	410
Comprehensive Income & Other	844.33	1,067	1,229	1,406	1,582	259.18
Shareholders' Equity	6,451	5,942	5,944	5,355	4,630	2,979
Total Liabilities & Equity	19,589	14,642	10,816	8,536	7,177	4,871
Total Debt	10,206	7,455	3,827	2,497	2,181	1,785
Net Cash (Debt)	-6,838	-6,978	-3,282	-2,153	-1,568	-1,488
Net Cash Per Share	-29.60	-30.21	-14.21	-9.32	-6.79	-6.44
Filing Date Shares Outstanding	231	231	231	231	231	231
Total Common Shares Outstanding	231	231	231	231	231	231
Working Capital	4,083	1,168	1,770	2,423	1,732	1,351
Book Value Per Share	27.93	25.72	25.73	23.18	20.04	12.90
Tangible Book Value	6,426	5,942	5,944	5,355	4,630	2,979
Tangible Book Value Per Share	27.82	25.72	25.73	23.18	20.04	12.90
Land	-	657.98	624.1	566.06	566.06	503.09
Buildings	-	1,083	978.41	978.41	978.41	978.41
Machinery	-	4,030	3,031	2,465	2,270	3,556
Construction In Progress	-	1,957	1,299	437.22	342.81	319.33

Source: S&P Capital IQ. Standard template. Financial Sources.